ANIMATION

Apoptosis and BCL-2

Share this animation:

ABT-199/GDC-0199 is a small molecule drug in co-development by Abbvie and Genentech for the selective inhibition of BCL-2, a key regulator of cellular apoptosis. BCL-2, part of the larger BCL-2 family, is responsible for the sequestration of pro-apoptopic proteins along the mitochondrial membrane. Displacement of these proteins from BCL-2 in cancerous cells may prime these cells for apoptosis.

Share It:
Contact XVIVO

Client


Abbvie; Genentech

I wanted to thank XVIVO for creating the animation and doing so at record speed! I received wonderful feedback from people at TED about the video – everyone thought it was so cool and wanted to know who made it.

President & CEO, The International AIDS Vaccine Initiative
Share this animation: